William B. Horne
Mr. Horne has served as a director for Alzamend Neuro™ since June 01, 2016 and was its Chief Financial Officer from this same time until December 15, 2018. Mr. Horne is a member of the board of directors of DPW Holdings, Inc. (NYSE.Mkt: DPW) since October 2016 and on January 25, 2018, Mr. Horne was appointed as DPW Holdings Chief Financial Officer. Mr. Horne is the Chief Financial Officer, Treasurer and a member of the Board of Directors for Avalanche International, Corp dba MTIX International, Inc., a publicly traded company and has held the same positions for Ault & Company, Inc., a private holding company, since January 2018. He has served as the Chief Financial Officer of Targeted Medical Pharma, Inc. (OTCBB: TRGM) since August 2013.
Mr. Horne previously held the position of Chief Financial Officer in various companies in the healthcare and high-tech field including OptimisCorp., from January 2008 to May 2013, a privately-held, diversified healthcare technology company located in Los Angeles, California.
Mr. Horne served as the Chief Financial Officer of Patient Safety Technologies, Inc. (OTCBB: PSTX), a medical device company located in Irvine, California, from June 2005 to October 2008 and as the interim Chief Executive Officer from January 2007 to April 2008. In his dual role at Patient Safety Technologies, Mr. Horne was directly responsible for structuring the divestiture of non-core assets, capital financings and debt restructuring.
Mr. Horne has also held supervisory positions at Price Waterhouse, LLP and has a Bachelor of Arts Magna Cum Laude in Accounting from Seattle University.
SUBSCRIBE TO OUR UPDATES: